192 related articles for article (PubMed ID: 10194140)
21. Diagnosis and management of neutrophilic myeloid neoplasms.
Schwede M; Gotlib J; Shomali W
Clin Adv Hematol Oncol; 2021 Jul; 19(7):450-459. PubMed ID: 34236344
[TBL] [Abstract][Full Text] [Related]
22. Chronic neutrophilic leukaemia.
Gan GG; Pasagna JF; Eow GI; Nadarajan VS
Singapore Med J; 2007 Mar; 48(3):e74-6. PubMed ID: 17342275
[TBL] [Abstract][Full Text] [Related]
23. Polycythemia vera in a patient with the human immunodeficiency virus: a case report.
Sassaki MG; Souza CA; Siciliano RF; Leite AG; Padilha SL
Braz J Infect Dis; 2000 Aug; 4(4):204-7. PubMed ID: 11184768
[TBL] [Abstract][Full Text] [Related]
24. Application of PRV-1 mRNA expression level and JAK2V617F mutation for the differentiating between polycytemia vera and secondary erythrocytosis and assessment of treatment by interferon or hydroxyurea.
Tutaeva V; Misurin AV; Michiels JJ; Rozenberg JM; Sokolova MA; Ivanova VL; Kolosheinova TI; Manakova TE; Levina AA; Semenova EA; Khoroshko ND
Hematology; 2007 Dec; 12(6):473-9. PubMed ID: 17852451
[TBL] [Abstract][Full Text] [Related]
25. Presence of the bcr/abl rearrangement in a patient with chronic neutrophilic leukaemia.
Christopoulos C; Kottoris K; Mikraki V; Anevlavis E
J Clin Pathol; 1996 Dec; 49(12):1013-5. PubMed ID: 9038742
[TBL] [Abstract][Full Text] [Related]
26. Transition of polycythemia vera to chronic myeloid leukaemia.
Saviola A; Fiorani C; Ferrara L; Mazzocchi V; Zucchini P; Temperani P; Longo G; Emilia G; Torelli G
Eur J Haematol; 2005 Sep; 75(3):264-6. PubMed ID: 16104886
[TBL] [Abstract][Full Text] [Related]
27. Presence of the JAK2 V617F mutation in a patient with chronic neutrophilic leukemia and effective response to interferon α-2b.
Zhang X; Pan J; Guo J
Acta Haematol; 2013; 130(1):44-6. PubMed ID: 23391844
[TBL] [Abstract][Full Text] [Related]
28. Evidence of clonality in chronic neutrophilic leukaemia.
Böhm J; Kock S; Schaefer HE; Fisch P
J Clin Pathol; 2003 Apr; 56(4):292-5. PubMed ID: 12663642
[TBL] [Abstract][Full Text] [Related]
29. Polycythemia vera and hydroxyurea resistance/intolerance: a monocentric retrospective analysis.
Demuynck T; Verhoef G; Delforge M; Vandenberghe P; Devos T
Ann Hematol; 2019 Jun; 98(6):1421-1426. PubMed ID: 30919072
[TBL] [Abstract][Full Text] [Related]
30. Survival in a patient with polycythaemia vera for over thirty years: implications for treatment decisions in younger patients.
Samuelsson J
Leuk Lymphoma; 1998 Dec; 32(1-2):195-8. PubMed ID: 10037017
[TBL] [Abstract][Full Text] [Related]
31. [A case of chronic neutrophilic leukemia associated with polycythemia vera].
Harada Y; Katano T; Nakamura Y; Adachi Y
Rinsho Ketsueki; 1993 Jun; 34(6):738-42. PubMed ID: 8366577
[TBL] [Abstract][Full Text] [Related]
32. Treatment of polycythemia vera with hydroxyurea.
Donovan PB; Kaplan ME; Goldberg JD; Tatarsky I; Najean Y; Silberstein EB; Knospe WH; Laszlo J; Mack K; Berk PD
Am J Hematol; 1984; 17(4):329-34. PubMed ID: 6496458
[TBL] [Abstract][Full Text] [Related]
33. Second line therapies in polycythemia vera: What is the optimal strategy after hydroxyurea failure?
Nazha A; Khoury JD; Verstovsek S; Daver N
Crit Rev Oncol Hematol; 2016 Sep; 105():112-7. PubMed ID: 27401783
[TBL] [Abstract][Full Text] [Related]
34. Can pegylated interferon improve the outcome of polycythemia vera patients?
Crisà E; Cerrano M; Beggiato E; Benevolo G; Lanzarone G; Manzini PM; Borchiellini A; Riera L; Boccadoro M; Ferrero D
J Hematol Oncol; 2017 Jan; 10(1):15. PubMed ID: 28086927
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of alpha interferon and hydroxyurea in late phase refractory myeloproliferative disease.
Litam PP; Landaw SA; Zamkoff KW
Haematologia (Budap); 1994; 26(2):87-90. PubMed ID: 7890266
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis and treatment of thrombocythemia in myeloproliferative disorders.
Gilbert HS
Oncology (Williston Park); 2001 Aug; 15(8):989-96, 998; discussion 999-1000,1006,1008. PubMed ID: 11548978
[TBL] [Abstract][Full Text] [Related]
37. Chronic neutrophilic leukemia, an extremely rare cause of neutrophilia in childhood: Cure with hematopoietic stem cell transplantation.
Uygun V; Daloğlu H; Öztürkmen S; Karasu G; Avcı Z; Yeşilipek A
Pediatr Transplant; 2018 Aug; 22(5):e13199. PubMed ID: 29676020
[TBL] [Abstract][Full Text] [Related]
38. IgA nephropathy in a patient with polycythemia vera. Clinical manifestation of chronic renal failure and heavy proteinuria.
Chung J; Park PG; Song KI
Am J Nephrol; 2002; 22(4):397-401. PubMed ID: 12169877
[TBL] [Abstract][Full Text] [Related]
39. A reappraisal of the benefit-risk profile of hydroxyurea in polycythemia vera: A propensity-matched study.
Barbui T; Vannucchi AM; Finazzi G; Finazzi MC; Masciulli A; Carobbio A; Ghirardi A; Tognoni G
Am J Hematol; 2017 Nov; 92(11):1131-1136. PubMed ID: 28699191
[TBL] [Abstract][Full Text] [Related]
40. Complex karyotype in a polycythemia vera patient with a novel SETD1B/GTF2H3 fusion gene.
Tiziana Storlazzi C; Pieri L; Paoli C; Daniele G; Lasho T; Tefferi A; Vannucchi AM
Am J Hematol; 2014 Apr; 89(4):438-42. PubMed ID: 24382738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
